Heart Health
Study puts hard numbers on cardiovascular risks of NSAIDs
A large study in The Lancet provides more details about the cardiovascular risks associated with high doses of anti-inflammatory pain medications. The review covered over 600 studies in which people took various types of nonsteroidal anti-inflammatory drugs (NSAIDs). These include the most widely consumed NSAIDs, including over-the counter ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn) as well as prescription-only diclofenac (Voltaren, Cataflam) and celecoxib (Celebrex).
The study found that taking high doses of most NSAIDs, except for naproxen, increases the risk of a variety of cardiovascular problems by about one-third. The hazards include heart attacks and strokes as well as death from cardiovascular causes.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.